Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The peptide editor TAPBPR is the newest member of the major histocompatibility complex class I (MHC-I) antigen processing and presentation pathway. Since 2013, studies have explored the functions and mechanisms of action of this tapasin homolog. Here, we review the key insights gained from structural studies of the TAPBPR:MHC-I complex and the involvement of the TAPBPR loop in peptide exchange. However, despite recent advances, the question still remains: why do we need TAPBPR? The recent appreciation that different MHC-I allotypes vary in their ability to interact with TAPBPR, together with a role for TAPBPR in alternative presentation pathways highlights that much remains unknown concerning the biological need for TAPBPR.

More information Original publication

DOI

10.1016/j.coi.2021.04.011

Type

Journal article

Publication Date

2021-06-01T00:00:00+00:00

Volume

70

Pages

90 - 94

Total pages

4

Addresses

D, e, p, a, r, t, m, e, n, t, , o, f, , P, a, t, h, o, l, o, g, y, ,, , U, n, i, v, e, r, s, i, t, y, , o, f, , C, a, m, b, r, i, d, g, e, ,, , T, e, n, n, i, s, , C, o, u, r, t, , R, o, a, d, ,, , C, a, m, b, r, i, d, g, e, ,, , C, B, 2, , 1, Q, P, ,, , U, n, i, t, e, d, , K, i, n, g, d, o, m, ;, , C, a, n, c, e, r, , R, e, s, e, a, r, c, h, , U, K, , C, a, m, b, r, i, d, g, e, , I, n, s, t, i, t, u, t, e, ,, , U, n, i, v, e, r, s, i, t, y, , o, f, , C, a, m, b, r, i, d, g, e, ,, , C, a, m, b, r, i, d, g, e, ,, , U, n, i, t, e, d, , K, i, n, g, d, o, m, .

Keywords

Humans, Peptides, Immunoglobulins, Membrane Proteins, Histocompatibility Antigens Class I, Antigen Presentation